News

2020-01-24 RE SGI: Updated Reciprocity Agreement Allows Insulin-Using Diabetics to Operate Commercial Vehicles in US

Jan 24, 2020

Effective Sept. 9, 2019 the prohibition on cross-border operations between Canada and the US for these drivers has been removed. Accordingly, SGI is removing the W restriction on the licences of insulin-dependent CMV drivers.

This update is the result of a Sept. 19, 2018 Federal Motor Carrier Safety Administration (FMCSA) ruling that permits an individual with a stable insulin regimen and properly controlled insulin-treated diabetes mellitus to be qualified to operate a CMV in the United States. The FMCSA and Transport Canada have exchanged letters to update the December 1998 Agreement under the North American Free Trade Agreement (NAFTA) for reciprocal recognition of medical fitness requirements for CMV operators.